Literature DB >> 25947039

Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population.

Marie Lange1,2,3, Natacha Heutte1,3, Nastassja Morel2, Francis Eustache2, Florence Joly1,3,4, Bénédicte Giffard2.   

Abstract

Cancer patients often report cognitive changes after chemotherapy. The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) is a self-report questionnaire that assesses these changes. The aims of the present study were (1) to establish normative data, and (2) to compare the scores of patients and healthy controls to assess whether or not the questionnaire is able to discriminate between these populations. The normative sample included 213 healthy participants. The patient group included 63 cancer patients treated with chemotherapy, who were compared to a subsample of 63 matched healthy controls. The questionnaire had good internal consistency reliability (Cronbach's alphas = .74-.91). The oldest patients had significantly more cognitive complaints (p < .001). Cognitive complaints were significantly related with Trail Making Test scores (p < .001). Furthermore, the FACT-Cog subscales correlated significantly with anxiety and depression. Patients had more complaints than matched controls on the subscales Perceived Cognitive Impairments (p = .01), Impact on Quality of Life (p = .001) and Perceived Cognitive Abilities (p = .027). The reference values from the healthy population reported here could be used for comparison with the values measured in French-speaking cancer patients. The values provide a benchmark against which clinicians can evaluate the impact of the disease and/or the treatments on cognitive complaints and help to improve quality of life by providing appropriate care.

Entities:  

Keywords:  Cancer; Cognitive complaints; Functional Assessment of Cancer Therapy (FACT); Normative data; Quality of Life

Mesh:

Year:  2015        PMID: 25947039     DOI: 10.1080/09602011.2015.1036890

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  6 in total

1.  Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.

Authors:  Chelsea Nicol; Tamara Ownsworth; Lee Cubis; William Nguyen; Matthew Foote; Mark B Pinkham
Journal:  J Cancer Surviv       Date:  2019-07-17       Impact factor: 4.442

2.  Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the "CAGE-Cog" study.

Authors:  Aline Hajj; Rita Khoury; Roula Hachem; Aya Awad; Souheil Hallit; Hala Sacre; Fady Nasr; Fadi El Karak; Georges Chahine; Joseph Kattan; Lydia Rabbaa Khabbaz
Journal:  BMC Cancer       Date:  2022-09-19       Impact factor: 4.638

Review 3.  Are Sleep Complaints Related to Cognitive Functioning in Non-Central Nervous System Cancer? A Systematic Review.

Authors:  Mylène Duivon; Bénédicte Giffard; Béatrice Desgranges; Joy Perrier
Journal:  Neuropsychol Rev       Date:  2021-08-05       Impact factor: 6.940

4.  Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors.

Authors:  Alan Kiang; Vivian K Weinberg; Ka Ho Nicholas Cheung; Erin Shugard; Josephine Chen; Jeanne M Quivey; Sue S Yom
Journal:  Radiat Oncol       Date:  2016-09-26       Impact factor: 3.481

5.  Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.

Authors:  Mélanie Dos Santos; Isabelle Hardy-Léger; Olivier Rigal; Idlir Licaj; Sarah Dauchy; Christelle Levy; Sabine Noal; Carine Segura; Corinne Delcambre; Djelila Allouache; Aurélie Parzy; Jérôme Barriere; Thierry Petit; Marie Lange; Aurélie Capel; Bénédicte Clarisse; Jean Michel Grellard; Johan Lefel; Florence Joly
Journal:  Cancer       Date:  2020-09-30       Impact factor: 6.860

6.  Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.

Authors:  Aline Hajj; Roula Hachem; Rita Khoury; Souheil Hallit; Bashar ElJEBBAWI; Fady Nasr; Fadi El Karak; Georges Chahine; Joseph Kattan; Lydia Rabbaa Khabbaz
Journal:  BMC Cancer       Date:  2021-07-30       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.